Search for: "Pacific Biosciences of California, Inc"
Results 1 - 20
of 21
Sorted by Relevance
|
Sort by Date
4 Dec 2017, 9:59 pm
By Donald Zuhn -- Last month, in Pacific Biosciences of California, Inc. v. [read post]
14 Jan 2024, 9:29 pm
Noonan -- The importance of claim construction, and how construing the same term facing a challenge based on different prior art in separate inter partes review proceedings can result in contrary findings on invalidity, was illustrated by the Federal Circuit's decision recently in Pacific Biosciences of California, Inc. v. [read post]
20 May 2021, 9:14 pm
Noonan -- The Federal Circuit continues its recent run of decisions extending the reach of the enablement requirement of 35 U.S.C. 112(a) to invalidate patents in Pacific Biosciences of California, Inc. v. [read post]
12 May 2021, 9:15 am
(collectively, Oxford) infringed all claims of Pacific Biosciences of California, Inc. [read post]
12 May 2021, 9:15 am
(collectively, Oxford) infringed all claims of Pacific Biosciences of California, Inc. [read post]
8 Jan 2020, 3:00 am
(“Illumina”) and Pacific Biosciences of California, Inc. [read post]
2 Mar 2020, 1:01 pm
Stark in Pacific Biosciences of California, Inc. v. [read post]
17 Nov 2019, 10:01 pm
In Pacific Biosciences of California, Inc. v. [read post]
12 Nov 2019, 12:26 pm
Hall in Pacific Biosciences of California, Inc. v. [read post]
17 Jun 2019, 7:51 am
Stark in Pacific Biosciences of California, Inc. v. [read post]
12 Nov 2019, 12:26 pm
Hall in Pacific Biosciences of California, Inc. v. [read post]
3 Feb 2011, 8:24 am
Pacific Biosciences of California, Inc. [read post]
3 Feb 2011, 8:24 am
Pacific Biosciences of California, Inc. [read post]
6 Jan 2020, 6:21 am
Illumina Inc. on Thursday agreed to terminate the $1.2 billion deal to buy smaller rival Pacific Biosciences of California Inc. [read post]
29 Jan 2018, 6:25 am
In his post he provides a short guide to clients' questions on the subject together with the bench's take in case Oxford Nanopore Technologies Ltd & Anor v Pacific Biosciences of California, Inc & Anor [2017] EWHC 3190 (Pat).Kat on a search to find Ultra Violet Then, a jump on the Trans-Siberian train to stop first in Russia which recently ratified the Hague Agreement. [read post]
15 Mar 2012, 10:10 am
Pacific Biosciences of California, Inc. [read post]
27 Apr 2016, 9:26 pm
Consider this 5-year settlement data extract: Entity Suit Year Settlement Year Settlement Amount California County CardioNet, Inc. 2009 2012 $7,250,000 San Diego Pacific Biosciences, Inc. 2011 2012 $7,686,494 San Mateo Envivio, Inc. 2012 2015 $8,500,000 San Mateo CafePress, Inc. 2013 2015 $8,000,000 San Mateo Audience, Inc. 2012 2015 $6,050,000 Santa Clara Model N, Inc. 2014 2015 $8,550,000 San Mateo Castlight… [read post]
7 Sep 2010, 6:10 pm
(Docket Report) US: Helicos Biosciences Corp files patent infringement suit against Pacific Biosciences of California in response to its manufacture and use of Single Molecule Real Time DNA sequencing technology (Patent Docs) US: Report predicts tough road ahead for some generics after Federal Circuit patent use code decisions (FDA Law Blog) Products Angiomax (Bivalirudin) – US: APP moves forward with appeal notice in Angiomax PTE litigation in light of… [read post]
23 Apr 2018, 1:20 am
Supreme Court issued its unanimous decision in Cyan, Inc. v. [read post]
15 Feb 2010, 2:20 pm
Opinion below (6th Circuit) Petition for certiorari Brief in opposition Petitioner’s reply Title: Pacific Investment Management Co. v. [read post]
